Oxford BioMedica (GB:OXB) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Oxford Biomedica has announced its total voting rights, with its issued share capital comprising 105,938,933 ordinary shares, reflecting its strategic position as a leader in cell and gene therapy. The company, renowned for its innovation in viral vector manufacturing, collaborates with top pharmaceutical firms globally. As a FTSE4Good constituent, OXB continues to drive advancements in the biotech sector from its multiple facilities across the UK, France, and the US.
For further insights into GB:OXB stock, check out TipRanks’ Stock Analysis page.